Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $36,792 - $40,571
183 Added 9.13%
2,187 $439,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $119,952 - $136,592
566 Added 39.36%
2,004 $483,000
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $306,754 - $370,759
1,438 New
1,438 $329,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $342,442 - $438,381
1,672 New
1,672 $342,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $1.03 Million - $1.33 Million
-4,803 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $236,292 - $273,362
-870 Reduced 15.34%
4,803 $1.51 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $1.56 Million - $1.75 Million
5,673 New
5,673 $1.6 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $1.6 Million - $1.77 Million
-6,368 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $1.3 Million - $1.62 Million
6,368 New
6,368 $1.62 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Srb Corp Portfolio

Follow Srb Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Srb Corp with notifications on news.